UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of Earliest Event Reported): July 2, 2003
ADVANCED MAGNETICS, INC.
(Exact name of registrant as specified in its charter)
Delaware |
|
Commission File No. 0-14732 |
|
04-2742593 |
(State or other
jurisdiction |
|
|
|
(I.R.S. Employer |
|
|
|
|
|
61
Mooney Street |
|
|
|
02138 |
(Address of principal executive offices) |
|
|
|
(Zip Code) |
Registrants telephone number, including area code: (617) 497-2070
Item 5. Other Events.
On June 18, 2003, Advanced Magnetics, Inc. announced the publication of clinical data in the New England Journal of Medicine showing that magnetic resonance imaging with Combidex®, the Companys investigational iron oxide nanoparticle used to aid in the diagnosis of lymph node disease, allows for the noninvasive assessment of lymph nodes in patients with prostate cancer. A copy of the press release is attached hereto as Exhibit 99.1.
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
|
ADVANCED MAGNETICS, INC. |
|
|
|
|
|
|
By: |
/s/ Jerome Goldstein |
|
|
Name: |
Jerome Goldstein |
|
|
Title: |
Chief Executive
Officer, President, |
|
Dated: July 2, 2003 |
|
|
|
3